{"id":24,"date":"2007-02-01T16:56:40","date_gmt":"2007-02-01T16:56:40","guid":{"rendered":"http:\/\/www.whistleblowerlawyerblog.com\/2007\/02\/government_joins_whistleblower.html"},"modified":"2021-06-11T17:56:59","modified_gmt":"2021-06-11T21:56:59","slug":"government_joins_whistleblower","status":"publish","type":"post","link":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/","title":{"rendered":"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs"},"content":{"rendered":"

We saw another significant whistleblower case against a drug company hit the news wire this week. <\/p>\n

The government announced that it was joining a qui tam lawsuit under the False Claims Act against the company Boehringer Ingelheim Roxane, Inc. The Complaint alleges overcharging on pharmaceutical products. <\/p>\n

In joining this lawsuit, the United States has alleged that the drug company engaged in a “scheme to report fraudulent and inflated prices for several pharmaceutical products, knowing that federal health care programs established reimbursement rates based on those reported prices.” <\/p>\n

We have reprinted the government’s announcement of why it is joining this qui tam whistleblower lawsuit below (from the U.S. Department of Justice<\/a> press release):<\/p>\n

+++++++++++++++++++++++++++++++++++++++++++++++++++++++
\n Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

We saw another significant whistleblower case against a drug company hit the news wire this week. The government announced that it was joining a qui tam lawsuit under the False Claims Act against the company Boehringer Ingelheim Roxane, Inc. The Complaint alleges overcharging on pharmaceutical products. In joining this lawsuit, the United States has alleged […]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,10],"tags":[],"class_list":["post-24","post","type-post","status-publish","format-standard","hentry","category-medicare-and-medicaid-fraud","category-pharmaceutical-fraud"],"yoast_head":"\nGovernment Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs — Whistleblower Lawyer Blog — February 1, 2007<\/title>\n<meta name=\"description\" content=\"We saw another significant whistleblower case against a drug company hit the news wire this week. The government announced that it was joining a qui tam — February 1, 2007\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs — Whistleblower Lawyer Blog — February 1, 2007\" \/>\n<meta name=\"twitter:description\" content=\"We saw another significant whistleblower case against a drug company hit the news wire this week. The government announced that it was joining a qui tam — February 1, 2007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michael Sullivan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs — Whistleblower Lawyer Blog — February 1, 2007","description":"We saw another significant whistleblower case against a drug company hit the news wire this week. The government announced that it was joining a qui tam — February 1, 2007","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/","twitter_card":"summary_large_image","twitter_title":"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs — Whistleblower Lawyer Blog — February 1, 2007","twitter_description":"We saw another significant whistleblower case against a drug company hit the news wire this week. The government announced that it was joining a qui tam — February 1, 2007","twitter_misc":{"Written by":"Michael Sullivan","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/#article","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/"},"author":{"name":"Michael Sullivan","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#\/schema\/person\/06cb979e5d74ec7f83f73b757da4331f"},"headline":"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs","datePublished":"2007-02-01T16:56:40+00:00","dateModified":"2021-06-11T21:56:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/"},"wordCount":630,"articleSection":["Medicare and Medicaid Fraud","Pharmaceutical Fraud"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/","url":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/","name":"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs — Whistleblower Lawyer Blog — February 1, 2007","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#website"},"datePublished":"2007-02-01T16:56:40+00:00","dateModified":"2021-06-11T21:56:59+00:00","author":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#\/schema\/person\/06cb979e5d74ec7f83f73b757da4331f"},"description":"We saw another significant whistleblower case against a drug company hit the news wire this week. The government announced that it was joining a qui tam — February 1, 2007","breadcrumb":{"@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/government_joins_whistleblower\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/"},{"@type":"ListItem","position":2,"name":"Government Joins Whistleblower Case Against Pharmaceutical Firm for Overcharging on Generic Drugs"}]},{"@type":"WebSite","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#website","url":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/","name":"Whistleblower Lawyer Blog","description":"Published by Whistleblower Attorneys \u2014 Finch McCranie, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/#\/schema\/person\/06cb979e5d74ec7f83f73b757da4331f","name":"Michael Sullivan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1c20f28ef8779909ce4423e28badc00a489c680349138c20442a37fb45a0e8cf?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1c20f28ef8779909ce4423e28badc00a489c680349138c20442a37fb45a0e8cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1c20f28ef8779909ce4423e28badc00a489c680349138c20442a37fb45a0e8cf?s=96&d=mm&r=g","caption":"Michael Sullivan"},"sameAs":["https:\/\/www.finchmccranie.com\/michael-a-sullivan.html"]}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts\/24","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/comments?post=24"}],"version-history":[{"count":1,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts\/24\/revisions"}],"predecessor-version":[{"id":2241,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/posts\/24\/revisions\/2241"}],"wp:attachment":[{"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/media?parent=24"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/categories?post=24"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/whistleblower-blog\/wp-json\/wp\/v2\/tags?post=24"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}